URAC announces seven in new PQM accreditation program
WASHINGTON The Utilization Review Accreditation Commission has announced that seven companies are in the final stages to achieve accreditation for new programs introduced yesterday under its Pharmacy Quality Management initiative.
The companies participated in URAC beta testing for one or both of the new accreditation programs, Mail Service and Specialty Pharmacy and are completing the process to achieve URAC accreditation.
The companies that participated in beta testing for URAC’s new accreditation programs and the first to pursue accreditation are:
- CVS Caremark (Mail Service and Specialty Pharmacy)
- Express Scripts (Mail Service and Specialty Pharmacy)
- Prescription Solutions, Inc. (Mail Service and Specialty Pharmacy)
- NextRx (Mail Service Pharmacy)
- Prime Therapeutics (Mail Service Pharmacy)
- Perform Rx (Specialty Pharmacy)
- Walgreens Specialty Pharmacy (Specialty Pharmacy)
Several other companies are in process to receive accreditation under URAC’s Mail Service or Specialty Pharmacy programs and will undergo review now that the standards are finalized. Those companies are:
- Acro Pharmaceutical Services (Specialty Pharmacy)
- Centric Health Resources (Specialty Pharmacy)
- Humana RightSourceRx Mail Service Pharmacy (Mail Service Pharmacy)
- WellDyneRx (Mail Service Pharmacy)
Additionally, the following companies are in the process to receive Pharmacy Benefit Management accreditation:
AIDS expert calls for increased funding, testing
MEXICO CITY Michael Weinstein, president of AIDS Healthcare Foundation, said that the United States must immediately appropriate $200 million in order to test 10 million people for the deadly disease over the next three years.
“Without an accurate picture of the epidemic, vastly underestimated for the past ten years, we have missed countless opportunities to intervene with effective public health strategies,” noted Weinstein.
He further stated that, “Identifying all those who are infected and linking them to treatment, is the only way to break the chain of new infections and begin to address the nation’s runaway epidemic.”
Two M.D.s plead guilty to illegal $126 million Internet pharmacy
WASHINGTON Two California doctors have pleaded guilty to conspiracy for their participation in an illegal Internet pharmacy business. The business, according to the Department of Justice, generated more than $126 million in revenue from sales.
The business, known as Affpower, involved Chandresh Shah and Gerald Morris, both M.D.s, who pleaded guilty back on July 8. The two, along with 16 other defendants were indicted on July 27.
According to the indictment, the Affpower enterprise sold controlled and non-controlled prescription drugs through numerous affiliated Web sites to customers who lacked prescriptions for the drugs from a personal physician. From August 2004 to June 2006, the Affpower enterprise allegedly received more than one million Internet orders for controlled and non-controlled prescription pharmaceuticals from customers in all 50 U.S. states.
Morris and Shah admitted Affpower enterprise doctors conducted no physical or mental examinations before issuing prescriptions, had no contact with customers and had no physician-patient relationship with any customer for whom the doctors prescribed drugs.
The trials are scheduled to take place in March and April.